Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: Safety and Efficaty of Nab-paclitaxel (Abraxane) in Combination With Carboplatin as First Line Treatment in Elderly Subjects With Advance Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Op
Brief Summary: Study comparing two regimens of nab-paclitaxel and carboplatin combination in elderly subject (≥ 70 years old) with advanced NSCLC